In brief: NPG #14 requires that, when an onsite pharmacy is not open 24/7, a qualified healthcare professional reviews each medication order in the pharmacist’s absence and a pharmacist reviews all those orders retrospectively once the pharmacy opens (Joint Commission, 2025). The literature treats prospective pharmacist order review as one of the most consistent safety barriers in hospitals; remote order review (telepharmacy) is the main way to extend it to nights and small hospitals (Schneider, 2013).
Prof. Dr. Mehmet Nurullah Kurutkan, Düzce University, Faculty of Business, Department of Health Management
Abstract. This chapter opens the series on the Joint Commission’s National Performance Goal #14 with the first requirement: medication order review when the pharmacy is closed. Drawing on 1,423 hospital records from a 4,936-record Web of Science corpus, it defines pharmacist order review, distinguishes it from clinical pharmacy, medication review and reconciliation, and maps the models used to cover nights and weekends (on-call pharmacists, 24-hour pharmacies, telepharmacy and retrospective review). The evidence is strongest for unit-based and routine pharmacist review during admission, and weakest for what happens in the hours when no pharmacist is present.
Series: Effectively Managing Medications (Joint Commission NPG #14)
- Series guide: Effectively Managing Medications (NPG #14)
- Part 1. Pharmacist Order Review When the Pharmacy Is Closed (you are here)
- Part 2. Automated Dispensing Cabinets and Overrides
- Part 3. Medication Selection, Procurement and Shortages
- Part 4. Perioperative and Procedural Medication Labeling
- Part 5. Medication Reconciliation
- Part 6. Anticoagulant Safety
- Part 7. Antimicrobial Stewardship in Hospitals
Learning objectives
After completing this chapter, the reader will be able to:
- Explain the NPG #14 requirement on order review when the pharmacy is not open 24/7 and the role of retrospective pharmacist review.
- Define prospective medication order review and distinguish it from clinical pharmacy services, medication review and medication reconciliation.
- Compare four coverage models for nights and weekends: 24-hour onsite pharmacy, on-call pharmacist, telepharmacy (remote order review) and non-pharmacist review with retrospective check.
- Summarise the evidence on how pharmacist review affects medication errors, adverse drug events and costs.
- Critically appraise why trials of pharmacist interventions after discharge often show no effect.
- Design a simple monitoring plan for after-hours order review in a hospital.
Key concepts: prospective medication order review, order verification, retrospective review, telepharmacy (remote order entry), pharmacist intervention, drug-related problem (DRP), clinical pharmacist, after-hours coverage
Contents
- 1. Introduction
- 2. History and development
- 3. Definitions and conceptual schema
- 4. Distinguishing neighbouring concepts
- 5. Types and classifications
- 6. Theoretical frameworks and models
- 7. Themes and bibliometric profile
- 8. The situation in Türkiye
- 9. Debates and contradictions in the literature
- 10. Measurement problems
- 11. Research gaps and agenda
- 12. Relevance today and practical implications
- Summary box, discussion questions, further reading, glossary and references
Method box: how this chapter was produced
| Component | Application |
|---|---|
| Source document | Joint Commission (2025), National Performance Goal #14 “Effectively Managing Medications” (formerly part of the National Patient Safety Goals). (Joint Commission, 2025) |
| Database and indexes | Web of Science Core Collection (SCI-EXPANDED, SSCI, ESCI) |
| Search strategy (series) | Seven component blocks derived from the NPG #14 requirements, a core medication safety block and a hospital context block; combined set #24 = ((#1 AND component blocks 1-4) OR medication reconciliation OR anticoagulant block) AND hospital block, OR the title-based stewardship block; filtered to articles and reviews, English, 2000-2026. |
| Component query (this chapter) | TS=("pharmacist review*" OR "pharmacist verification" OR "pharmacist order review" OR "medication order review" OR "order verification" OR "after-hours pharmacy" OR "after-hours pharmacist*" OR "pharmacy after hours" OR "24-hour pharmacy" OR "overnight pharmacy" OR "night pharmacist*" OR "remote order entry" OR "remote order verification" OR telepharmacy OR "pharmacist intervention*" OR "clinical pharmacist*"), combined with the core medication safety block |
| Core block | TS=("medication safety" OR "medication error*" OR "medication mistake*" OR "drug error*" OR "prescribing error*" OR "prescription error*" OR "dispensing error*" OR "administration error*" OR "transcription error*" OR "adverse drug event*" OR "preventable adverse drug*" OR "medication-related harm" OR "medication incident*" OR "medication management" OR "medication use process" OR "safe medication" OR "high-alert medication*" OR "wrong drug" OR "wrong dose" OR "wrong route") |
| Search date and span | 16 November 2026; publication years 2000-2026 (2027 early-access records retained) |
| Inclusion and exclusion | Included: hospital-context records matching this component. Excluded: retracted publications and records whose only labeling match was “open-label”. |
| Screening counts | Series corpus 4,936; tagged for this component 1,425; excluded 2; eligible 1,423; core evidence set (component term in title or author keywords) 567; “patient safety” framed 304. |
| Evidence extraction | Definitions, milestones, models, measures, debates and gaps were extracted from the abstracts of the most cited and most recent records in the core set. |
| Limitations | Single database; English only; component tagging is rule based and reproduces the WoS query on title, abstract and keywords (agreement within 5 records per component); evidence read at abstract level; full texts were not read. |
1. Introduction
A nurse on a night shift receives a new order for intravenous potassium at 02:00. In many hospitals no pharmacist is on site at that hour. Someone must still check that the drug, dose, route and timing make sense for this patient before the first dose is given. NPG #14 turns that “someone” into a formal requirement: a qualified healthcare professional reviews the order in the pharmacist’s absence, and a pharmacist conducts a retrospective review of all such orders when the pharmacy opens (Joint Commission, 2025).
The requirement matters because order review is the step where many prescribing errors are caught before they reach the patient. French data from the Act-IP observatory show that pharmacists’ interventions during routine order review are more frequent when the pharmacist is regularly present on the ward, and are concentrated in high-risk areas such as paediatrics and intensive care (Bedouch et al., 2015). Order review is therefore not a clerical step but a safety barrier whose strength depends on who performs it and when.
This chapter asks three questions: what exactly is being reviewed, how hospitals cover the hours when the pharmacy is closed, and what the evidence says about the safety value of each arrangement.
2. History and development
The clinical role of hospital pharmacists expanded long before the Joint Commission wrote it into a goal. By 2006 a systematic review could already conclude that pharmacists’ participation in rounds, interviews and discharge counselling improved outcomes of hospitalised patients (Kaboli et al., 2006). In paediatrics, a full-time unit-based clinical pharmacist substantially reduced serious medication errors in an intensive care unit, whereas part-time coverage of general units did not (Kaushal et al., 2008), an early sign that the intensity of presence matters.
National surveys of the American Society of Health-System Pharmacists in 2005 and 2008 documented how new technology was changing medication distribution while pharmacists continued to improve the dispensing and administration steps (Pedersen et al., 2006; Pedersen et al., 2009). Telepharmacy entered the debate around 2010, when a study of rural hospitals found that remote models were spreading unevenly and that many states had not yet defined rules for them (Casey et al., 2010). In the same year the Joint Commission elevated medication safety to a National Patient Safety Goal (Joint Commission, 2025).
The decisive empirical step for after-hours coverage came in 2013, when remote pharmacist review of orders in three small community hospitals during closed hours was followed by fewer reported potential adverse drug events and higher nurse job satisfaction (Schneider, 2013). Since 2015 the literature has shifted toward large datasets of pharmacist interventions (Bedouch et al., 2015) and pragmatic trials across transitions of care (Gurwitz et al., 2021; Ravn-Nielsen et al., 2018). In 2025 the requirement became part of NPG #14 (Joint Commission, 2025).
3. Definitions and conceptual schema
The corpus rarely defines order review in one sentence; most definitions are operational and come from studies that count pharmacist interventions. Table 1 brings together the definitions that shape this requirement.
| Source | Year | Discipline | Definition (paraphrased) | Emphasised dimension |
|---|---|---|---|---|
| Joint Commission (2025) | 2025 | Accreditation | When the pharmacy is closed, a qualified professional reviews the order; a pharmacist later reviews all such orders retrospectively. | Continuity of the review barrier over 24 hours |
| Bedouch et al. (2015) | 2015 | Clinical pharmacy | Routine pharmacist review of medication orders that generates documented interventions to prevent drug-related problems. | Interventions as the observable output |
| Kaushal et al. (2008) | 2008 | Paediatrics, patient safety | Serious medication errors are preventable adverse drug events plus non-intercepted near misses; the pharmacist is a unit-based barrier against them. | Interception of errors before harm |
| Schneider (2013) | 2013 | Health-system pharmacy | Remote review of medication orders by pharmacists when the hospital pharmacy is closed. | Coverage of closed hours |
| Sankaranarayanan et al. (2014) | 2014 | Telemedicine | Pharmaceutical care delivered remotely, evaluated through documented remote pharmacist interventions within a conceptual framework. | Patient and system-centred remote care |
The common core is a pharmacist’s (or a qualified substitute’s) check of an order against the patient’s data before or soon after administration. The definitions diverge on timing (prospective or retrospective), location (on the unit, in the central pharmacy or remote), who may act as reviewer, and whether the output is measured as interventions, intercepted errors or patient outcomes.
4. Distinguishing neighbouring concepts
Order review is easily confused with three neighbouring activities. Clinical pharmacy services are the broader professional role that includes rounds, counselling and therapeutic drug monitoring (Kaboli et al., 2006). Medication review is a structured evaluation of a patient’s whole regimen aimed at optimising therapy, usually for older people with polypharmacy (Bülow et al., 2023). Medication reconciliation compares the medication list across a transition of care (Part 5 of this series).
Order review differs from all three because it is triggered by a single new order and works as a gate in the medication-use process: the order is checked before (or immediately after) it is acted on. Figure 4 summarises the criteria.
5. Types and classifications
The corpus describes four ways of covering the hours when the onsite pharmacy is closed.
| Model | How it works | Evidence in the corpus |
|---|---|---|
| 24-hour onsite pharmacy | A pharmacist is present at all times, sometimes with a dedicated emergency department service. | A 24-hour emergency department pharmacy programme was reported as efficient and cost saving (Aldridge et al., 2009). |
| Remote order review (telepharmacy) | An offsite pharmacist reviews and verifies orders electronically during closed hours. | Fewer reported potential adverse drug events and more interventions after implementation (Schneider, 2013); uneven regulation (Casey et al., 2010). |
| On-call pharmacist | A pharmacist can be contacted for urgent questions but does not review every order. | Little direct evaluation; usually described as part of mixed models (Casey et al., 2010). |
| Non-pharmacist review plus retrospective check | A physician or nurse reviews the order; a pharmacist reviews all orders when the pharmacy opens. | The minimum required by NPG #14 (Joint Commission, 2025); no corpus study isolates its safety effect. |
A second classification concerns the type of problem detected. Pharmacist interventions are usually coded as dose adjustments, drug interactions, untreated indications, unnecessary drugs or inappropriate routes and forms, as in Turkish studies in oncology and geriatrics (Ertuna et al., 2019; Umar et al., 2020).
6. Theoretical frameworks and models
Three frameworks organise the literature. The first is the medication-use process, in which errors can arise at prescribing, dispensing and administration (Berdot et al., 2012): order review sits between prescribing and dispensing and can intercept errors before they travel downstream. The second is the layered defence logic of patient safety: a pharmacist on the unit adds an independent layer, and the effect depends on whether the layer is present full time (Kaushal et al., 2008).
The third is a service-evaluation framework for telepharmacy that classifies remote interventions by patient-centred and system-centred value (Sankaranarayanan et al., 2014). Economic evaluations add a fourth lens, translating interventions into cost avoidance (De Rijdt et al., 2008; Gallagher et al., 2014).
7. Themes and bibliometric profile
The eligible subcorpus holds 1,423 records (199 of them reviews) with 33,420 citations in the WoS Core Collection. 120 records appeared in 2000-2010 and 1,088 in 2016-2026, so most of the evidence is recent (Figure 5). The leading journals are International Journal of Clinical Pharmacy (101), American Journal of Health-system Pharmacy (86), Research in Social & Administrative Pharmacy (35), European Journal of Hospital Pharmacy (33). By author address the most active countries are United States (404), Australia (124), China (88), France (83), England (75). The most frequent author keywords are: medication errors, clinical pharmacist, medication safety, clinical pharmacy, pharmacist, medication reconciliation, pharmacists, patient safety, medication error, drug-related problems. 304 records (21%) explicitly frame their topic with the term “patient safety”.
Four themes dominate. (1) Error interception: pharmacists in hospitals and emergency departments identify and reduce medication errors and conduct admission histories (Cohen et al., 2009). (2) Transitions of care: a large share of recent trials evaluate pharmacist interventions at discharge (De Oliveira et al., 2021; Ravn-Nielsen et al., 2018). (3) Economics: interventions are converted into cost avoidance (Gallagher et al., 2014). (4) Remote services: telepharmacy and telehealth medication reviews expanded rapidly, including during COVID-19 (Hanjani et al., 2020; Li et al., 2021).
8. The situation in Türkiye
The subcorpus contains 24 records with a Turkish address. Studies from Turkish university hospitals document drug-related problems found by clinical pharmacists in intensive care (Albayrak et al., 2022), oncology wards (Umar et al., 2020) and geriatric wards (Ertuna et al., 2019), with high acceptance of recommendations by physicians. One study states that clinical pharmacy services are still not properly implemented in Türkiye (Ertuna et al., 2019). No corpus record evaluates after-hours or remote order review in a Turkish hospital, so the evidence base for applying this NPG #14 requirement in Türkiye is indirect.
9. Debates and contradictions in the literature
Axis 1: does pharmacist review change patient outcomes? A multifaceted in-hospital pharmacist intervention reduced emergency visits and readmissions (Ravn-Nielsen et al., 2018), and a meta-analysis found fewer medication errors after discharge (De Oliveira et al., 2021). Yet two randomised trials found no significant reduction in clinically important medication errors or adverse drug events after discharge (Gurwitz et al., 2021; Kripalani et al., 2012). The contradiction suggests that the effect depends on the setting, the intensity of the intervention and the outcome counted.
Axis 2: is presence or process the active ingredient? Full-time unit-based pharmacists reduced serious errors while part-time coverage did not (Kaushal et al., 2008), and interventions are more frequent when pharmacists are regularly on the ward (Bedouch et al., 2015). Telepharmacy evidence, in contrast, implies that a remote process can substitute for presence during closed hours (Schneider, 2013). The two positions have not been tested against each other.
Axis 3: who may review when the pharmacist is absent? NPG #14 accepts a qualified healthcare professional plus retrospective pharmacist review (Joint Commission, 2025). Telepharmacy studies show that regulation of remote practice lags behind use (Casey et al., 2010). Whether a physician’s or nurse’s review offers the same barrier as a pharmacist’s is not answered in the corpus.
10. Measurement problems
Most studies measure order review through the number and type of pharmacist interventions and their acceptance rate (Bedouch et al., 2015; Ertuna et al., 2019). This is a process measure: a high intervention count may reflect poor prescribing rather than effective review. Studies that count reported potential adverse drug events (Schneider, 2013) rely on voluntary reporting, which changes when staff attention changes.
Outcome trials face low event rates and recruitment problems that make null results hard to interpret (Gurwitz et al., 2021). Economic studies convert interventions into cost avoidance with assumptions that vary widely, and reviewers have called for comparative designs with incremental cost-effectiveness ratios (De Rijdt et al., 2008). No standard indicator exists for the quality of the retrospective review that NPG #14 requires.
11. Research gaps and agenda
The following questions are framed so that they can be answered by empirical studies; each notes the evidence gap it derives from.
- Does non-pharmacist order review during closed hours, followed by retrospective pharmacist review, intercept as many clinically significant errors as remote pharmacist review? (No comparative study in the corpus.)
- What proportion of errors found in retrospective review had already reached the patient, and with what harm? (Retrospective review is required but not evaluated.)
- Which order types (high-alert drugs, paediatric doses, first doses) should be prioritised when only partial after-hours review is possible? (Interventions cluster in paediatrics and intensive care, but no prioritisation rule is tested.)
- Is the effect of pharmacist presence dose dependent across the 24-hour cycle? (Evidence comes from contrasting full-time and part-time units only.)
- How can telepharmacy be regulated and audited in countries such as Türkiye where hospital clinical pharmacy is still developing? (No Turkish study of remote review.)
- Which outcome measure is sensitive enough to detect the effect of order review in trials with low event rates? (Null trials cite low event numbers.)
12. Relevance today and practical implications
For hospital managers the requirement translates into three decisions: who reviews orders when the pharmacy is closed, how that review is documented, and how the pharmacist’s retrospective review is completed and fed back. Remote order review is the best-supported option for small hospitals (Schneider, 2013); where it is not possible, a written protocol for non-pharmacist review of high-alert drugs and a time limit for the retrospective review are the minimum. Monitoring should include the share of orders reviewed before the first dose, the number of retrospective findings that reached the patient, and the acceptance rate of pharmacist recommendations.
Summary box
- NPG #14 requires continuous order review: a qualified professional when the pharmacy is closed and a retrospective pharmacist review afterwards.
- Order review is a gate in the medication-use process; it differs from clinical pharmacy, medication review and reconciliation.
- Coverage models range from 24-hour pharmacies to telepharmacy and non-pharmacist review with retrospective check.
- Remote pharmacist review during closed hours was followed by fewer reported potential adverse drug events.
- Trials after discharge show mixed results, so the effect depends on setting, intensity and outcome.
- In Türkiye, clinical pharmacy evidence exists for wards but not for after-hours review.
Discussion questions
- Why does NPG #14 require a retrospective pharmacist review even when a qualified professional has already reviewed the order?
- Compare on-call and remote order review models: which risks does each leave uncovered?
- Why might a full-time unit-based pharmacist be more effective than part-time coverage?
- Two trials found no effect of pharmacist interventions after discharge. Does this weaken the case for order review in hospital? Explain.
- Application: draft a one-page protocol for night-time review of high-alert medication orders in a 150-bed hospital without a night pharmacist.
- Application: choose three indicators to monitor after-hours order review and explain how you would collect them.
Further reading
- Kaboli et al. (2006): the classic review of what clinical pharmacists add to inpatient care.
- Schneider (2013): the key evaluation of remote order review during closed hours.
- Kaushal et al. (2008): shows why full-time presence matters.
- Bedouch et al. (2015): large-scale view of what routine order review detects.
- Gurwitz et al. (2021): a carefully reported null trial that teaches how to read negative evidence.
- Joint Commission (2025): the two-page source of the requirement.
Glossary
| Term | Turkish | Short definition |
|---|---|---|
| Medication order review | İlaç order incelemesi | Check of a new order against patient data before the dose is given. |
| Retrospective review | Geriye dönük inceleme | Pharmacist review of orders already acted on during closed hours. |
| Telepharmacy | Uzaktan eczacılık | Pharmacy services, including order review, delivered from a remote site. |
| Pharmacist intervention | Eczacı müdahalesi | A documented recommendation or change made by a pharmacist. |
| Drug-related problem | İlaçla ilişkili sorun | An event involving drug therapy that interferes with desired outcomes. |
| Near miss | Ramak kala | An error caught before it reaches the patient. |
| Clinical pharmacist | Klinik eczacı | Pharmacist working with the care team on patient-level drug therapy. |
References
Albayrak, A., Basgut, B., Bikmaz, G. A., & Karahalil, B. (2022). Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital. BMC Health Services Research, 22(1), 79. https://doi.org/10.1186/s12913-022-07494-5
Aldridge, V. E., Park, H. K., Bounthavong, M., & Morreale, A. P. (2009). Implementing a comprehensive, 24-hour emergency department pharmacy program. American Journal of Health-system Pharmacy, 66(21), 1943-1947. https://doi.org/10.2146/ajhp080660
Bedouch, P., Sylvoz, N., Charpiat, B., Juste, M., Roubille, R., Rose, F. X., Bosson, J. L., Conort, O., & Allenet, B. (2015). Trends in pharmacists’ medication order review in French hospitals from 2006 to 2009: analysis of pharmacists’ interventions from the Act-IP© website observatory. Journal of Clinical Pharmacy and Therapeutics, 40(1), 32-40. https://doi.org/10.1111/jcpt.12214
Berdot, S., Sabatier, B., Gillaizeau, F., Caruba, T., Prognon, P., & Durieux, P. (2012). Evaluation of drug administration errors in a teaching hospital. BMC Health Services Research, 12, 60. https://doi.org/10.1186/1472-6963-12-60
Bülow, C., Clausen, S. S., Lundh, A., & Christensen, M. (2023). Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database of Systematic Reviews, CD008986. https://doi.org/10.1002/14651858.CD008986.pub4
Casey, M. M., Sorensen, T. D., Elias, W., Knudson, A., & Gregg, W. (2010). Current practices and state regulations regarding telepharmacy in rural hospitals. American Journal of Health-system Pharmacy, 67(13), 1085-1092. https://doi.org/10.2146/ajhp090531
Cohen, V., Jellinek, S. P., Hatch, A., & Motov, S. (2009). Effect of clinical pharmacists on care in the emergency department: A systematic review. American Journal of Health-system Pharmacy, 66(15), 1353-1361. https://doi.org/10.2146/ajhp080304
De Oliveira, G. S. J., Castro-Alves, L. J., Kendall, M. C., & McCarthy, R. (2021). Effectiveness of Pharmacist Intervention to Reduce Medication Errors and Health-Care Resources Utilization After Transitions of Care: A Meta-analysis of Randomized Controlled Trials. Journal of Patient Safety, 17(5), 375-380. https://doi.org/10.1097/PTS.0000000000000283
De Rijdt, T., Willems, L., & Simoens, S. (2008). Economic effects of clinical pharmacy interventions: A literature review. American Journal of Health-system Pharmacy, 65(12), 1161-1172. https://doi.org/10.2146/ajhp070506
Ertuna, E., Arun, M. Z., Ay, S., Koçak, F. K., Gökdemir, B., & Ispirli, G. (2019). Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study. Clinical Interventions in Aging, 14, 587-600. https://doi.org/10.2147/CIA.S201039
Gallagher, J., Byrne, S., Woods, N., Lynch, D., & McCarthy, S. (2014). Cost-outcome description of clinical pharmacist interventions in a university teaching hospital. BMC Health Services Research, 14, 177. https://doi.org/10.1186/1472-6963-14-177
Gurwitz, J. H., Kapoor, A., Garber, L., Mazor, K. M., Wagner, J., Cutrona, S. L., Singh, S., Kanaan, A. O., Donovan, J. L., Crawford, S., Anzuoni, K., Konola, T. J., Zhou, Y. H., & Field, T. S. (2021). Effect of a Multifaceted Clinical Pharmacist Intervention on Medication Safety After Hospitalization in Persons Prescribed High-risk Medications A Randomized Clinical Trial. JAMA Internal Medicine, 181(5), 610-618. https://doi.org/10.1001/jamainternmed.2020.9285
Hanjani, L. S., Caffery, L. J., Freeman, C. R., Peeters, G., & Peel, N. M. (2020). A scoping review of the use and impact of telehealth medication reviews. Research in Social & Administrative Pharmacy, 16(8), 1140-1153. https://doi.org/10.1016/j.sapharm.2019.12.014
Joint Commission. (2025). Effectively managing medications (National Performance Goal #14) [Fact sheet]. https://digitalassets.jointcommission.org/api/public/content/d0c3745c2d7e494ca5199bd3af2a13bc
Kaboli, P. J., Hoth, A. B., McClimon, B. J., & Schnipper, J. L. (2006). Clinical pharmacists and inpatient medical care – A systematic review. Archives of Internal Medicine, 166(9), 955-964. https://doi.org/10.1001/archinte.166.9.955
Kaushal, R., Bates, D. W., Abramson, E. L., Soukup, J. R., & Goldmann, D. A. (2008). Unit-based clinical pharmacists’ prevention of serious medication errors in pediatric inpatients. American Journal of Health-system Pharmacy, 65(13), 1254-1260. https://doi.org/10.2146/ajhp070522
Kripalani, S., Roumie, C. L., Dalal, A. K., Cawthon, C., Businger, A., Eden, S. K., Shintani, A., Sponsler, K. C., Harris, L. J., Theobald, C., Huang, R. L., Scheurer, D., Hunt, S., Jacobson, T. A., Rask, K. J., Vaccarino, V., Gandhi, T. K., Bates, D. W., Williams, M. V., & Schnipper, J. L. (2012). Effect of a Pharmacist Intervention on Clinically Important Medication Errors After Hospital Discharge A Randomized Trial. Annals of Internal Medicine, 157(1), 1-U35. https://doi.org/10.7326/0003-4819-157-1-201207030-00003
Li, H. B., Zheng, S. Q., Liu, F., Liu, W., & Zhao, R. S. (2021). Fighting against COVID-19: Innovative strategies for clinical pharmacists. Research in Social & Administrative Pharmacy, 17(1), 1813-1818. https://doi.org/10.1016/j.sapharm.2020.04.003
Pedersen, C. A., Schneider, P. J., & Scheckelhoff, D. J. (2006). ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration – 2005. American Journal of Health-system Pharmacy, 63(4), 327-345. https://doi.org/10.2146/ajhp050538
Pedersen, C. A., Schneider, P. J., & Scheckelhoff, D. J. (2009). ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration-2008. American Journal of Health-system Pharmacy, 66(10), 926-946. https://doi.org/10.2146/ajhp080715
Ravn-Nielsen, L. V., Duckert, M. L., Lund, M. L., Henriksen, J. P., Nielsen, M. L., Eriksen, C. S., Buck, T. C., Pottegård, A., Hansen, M. R., & Hallas, J. (2018). Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission A Randomized Clinical Trial. JAMA Internal Medicine, 178(3), 375-382. https://doi.org/10.1001/jamainternmed.2017.8274
Sankaranarayanan, J., Murante, L. J., & Moffett, L. M. (2014). A Retrospective Evaluation of Remote Pharmacist Interventions in a Telepharmacy Service Model Using a Conceptual Framework. Telemedicine and E-health, 20(10), 893-901. https://doi.org/10.1089/tmj.2013.0362
Schneider, P. J. (2013). Evaluating the impact of telepharmacy. American Journal of Health-system Pharmacy, 70(23), 2130-2135. https://doi.org/10.2146/ajhp130138
Umar, R. M., Apikoglu-Rabus, S., & Yumuk, P. F. (2020). Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients. International Journal of Clinical Pharmacy, 42(2), 652-661. https://doi.org/10.1007/s11096-020-00992-8
Source verification note
Author names, year, journal and DOI details of the 23 corpus-based citations were generated by code directly from the Web of Science records and checked one to one against the in-text citations; claims were checked at the level of record abstracts, and full texts were not read. The Joint Commission fact sheet was read in full on 16 November 2026. No source outside the corpus and the fact sheet is cited.
AI use statement
Anthropic’s Claude model was used to design and run the Web of Science search, tag and pre-screen records, extract evidence from abstracts, draft the English text and produce the figures. Final decisions, the scientific accuracy of the text and final responsibility rest with the author.
Data and supplementary material
The full list of the 567 core records and the 1,423 eligible records for this part (author, year, title, journal, DOI, component flags, “patient safety” layer flag and pre-screening suggestion), the screening log of the 4,936-record series corpus and the citation verification report are provided in the series companion workbook (NPG14_Series_Supplementary.xlsx), available from the author on request. The record list is deliberately kept out of the chapter text.
Series: Effectively Managing Medications (Joint Commission NPG #14)
- Series guide: Effectively Managing Medications (NPG #14)
- Part 1. Pharmacist Order Review When the Pharmacy Is Closed (you are here)
- Part 2. Automated Dispensing Cabinets and Overrides
- Part 3. Medication Selection, Procurement and Shortages
- Part 4. Perioperative and Procedural Medication Labeling
- Part 5. Medication Reconciliation
- Part 6. Anticoagulant Safety
- Part 7. Antimicrobial Stewardship in Hospitals
Cite this page (APA 7)
Kurutkan, M. N. (2026, November 16). Pharmacist Order Review When the Pharmacy Is Closed: An Introduction (101). The Health Topics. https://healthtopic.org/topics/pharmacist-order-review-when-the-pharmacy-is-closed-an-introduction-101/
